Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human KIAA1199 ELISA Kit (AC3601)
Cat.#: ASET-2190
Specifications
Description Human KIAA1199 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human KIAA1199 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.026 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.75-12 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1971 Canine Adiponectin ELISA Kit (AC3382) Quantitative inquiry ASET-1822 Human CDK5R1 ELISA Kit (AC3233) Quantitative inquiry ASET-1915 Human SNAP29 ELISA Kit (AC3326) Quantitative inquiry ASET-2114 Human SPON2 ELISA Kit (AC3525) Quantitative inquiry ASET-2453 Human CLSTN1 ELISA Kit (AC3864) Quantitative inquiry ASET-2367 Rat GLP1 ELISA Kit (AC3778) Quantitative inquiry ASET-1959 Sheep TSH ELISA Kit (AC3370) Quantitative inquiry ASET-2249 Mouse Pcsk1n ELISA Kit (AC3660) Quantitative inquiry ASET-1721 Rat Mitofusin 1 ELISA Kit (AC3132) Quantitative inquiry ASET-1405 Human Thimet Oligopeptidase ELISA Kit (AC2816) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket